Migraine Drugs Market Report

China Migraine Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Sep 10, 2023
  • PAGES：164
  • REPORT CODE：GMM1786113
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Migraine Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Pfizer

    • Pfizer

    • Allergan

    • Winston Pharmaceuticals

    • Teva

    • Ethypharm

    • Impax

    • Bayer

    • Kowa Pharmaceuticals America

    • Endo International

    • Johnson & Johnson

    • Eli Lilly

    • GlaxoSmithKline

    By Type:

    • Sumatriptan

    • Rizatriptan

    • Other Drug

    • Zolmitriptan

    By Application:

    • Others

    • Household Use

    • Clinics

    • Hospitals

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Migraine Drugs Market Overview 2018-2029

    • 1.1 China Migraine Drugs Industry Development Overview

    • 1.2 China Migraine Drugs Industry Development History

    • 1.3 China Migraine Drugs Industry Market Size (2018-2029)

    • 1.4 China Migraine Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Migraine Drugs Production Volume, Production Value and Growth Rate of Sumatriptan (2018-2029)

      • 1.4.2 China Migraine Drugs Production Volume, Production Value and Growth Rate of Rizatriptan (2018-2029)

      • 1.4.3 China Migraine Drugs Production Volume, Production Value and Growth Rate of Other Drug (2018-2029)

      • 1.4.4 China Migraine Drugs Production Volume, Production Value and Growth Rate of Zolmitriptan (2018-2029)

    • 1.5 China Migraine Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Migraine Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Migraine Drugs Sales Volume, Sales Value and Growth Rate of Household Use (2018-2029)

      • 1.5.3 China Migraine Drugs Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

      • 1.5.4 China Migraine Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • 1.6 China Migraine Drugs Market Analysis by Region

      • 1.6.1 North China Migraine Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Migraine Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Migraine Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Migraine Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Migraine Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Migraine Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Migraine Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Migraine Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Migraine Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Migraine Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Migraine Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Migraine Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Migraine Drugs Industry Development

    Chapter 3 Migraine DrugsIndustry Chain Analysis

    • 3.1 Migraine Drugs Industry Chain

    • 3.2 Migraine Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Migraine Drugs Market

    • 3.3 Migraine Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Migraine Drugs Market

    Chapter 4 China Migraine Drugs Market, by Type

    • 4.1 China Migraine Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Migraine Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Migraine Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Migraine Drugs Production Volume and Growth Rate of Sumatriptan

      • 4.5.2 China Migraine Drugs Production Volume and Growth Rate of Rizatriptan

      • 4.5.3 China Migraine Drugs Production Volume and Growth Rate of Other Drug

      • 4.5.4 China Migraine Drugs Production Volume and Growth Rate of Zolmitriptan

    Chapter 5 China Migraine Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Migraine Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Migraine Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Migraine Drugs Market Size and Growth Rate of Others

      • 5.5.2 China Migraine Drugs Market Size and Growth Rate of Household Use

      • 5.5.3 China Migraine Drugs Market Size and Growth Rate of Clinics

      • 5.5.4 China Migraine Drugs Market Size and Growth Rate of Hospitals

    Chapter 6 China Migraine Drugs Market, by Region

    • 6.1 China Migraine Drugs Production Volume and Production Value, by Region

    • 6.2 China Migraine Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Migraine Drugs Market Analysis

    • 7.1 North China Migraine Drugs Market, by Type

    • 7.2 North China Migraine Drugs Market, by Application

    Chapter 8 Central China Migraine Drugs Market Analysis

    • 8.1 Central China Migraine Drugs Market, by Type

    • 8.2 Central China Migraine Drugs Market, by Application

    Chapter 9 South China Migraine Drugs Market Analysis

    • 9.1 South China Migraine Drugs Market, by Type

    • 9.2 South China Migraine Drugs Market, by Application

    Chapter 10 East China Migraine Drugs Market Analysis

    • 10.1 East China Migraine Drugs Market, by Type

    • 10.2 East China Migraine Drugs Market, by Application

    Chapter 11 Northeast China Migraine Drugs Market Analysis

    • 11.1 Northeast China Migraine Drugs Market, by Type

    • 11.2 Northeast China Migraine Drugs Market, by Application

    Chapter 12 Southwest China Migraine Drugs Market Analysis

    • 12.1 Southwest China Migraine Drugs Market, by Type

    • 12.2 Southwest China Migraine Drugs Market, by Application

    Chapter 13 Northwest China Migraine Drugs Market Analysis

    • 13.1 Northwest China Migraine Drugs Market, by Type

    • 13.2 Northwest China Migraine Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Pfizer

        • 14.1.1 Pfizer Company Profile

        • 14.1.2 Pfizer Migraine Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Pfizer

        • 14.2.1 Pfizer Company Profile

        • 14.2.2 Pfizer Migraine Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Allergan

        • 14.3.1 Allergan Company Profile

        • 14.3.2 Allergan Migraine Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Winston Pharmaceuticals

        • 14.4.1 Winston Pharmaceuticals Company Profile

        • 14.4.2 Winston Pharmaceuticals Migraine Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Teva

        • 14.5.1 Teva Company Profile

        • 14.5.2 Teva Migraine Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Ethypharm

        • 14.6.1 Ethypharm Company Profile

        • 14.6.2 Ethypharm Migraine Drugs Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Impax

        • 14.7.1 Impax Company Profile

        • 14.7.2 Impax Migraine Drugs Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Bayer

        • 14.8.1 Bayer Company Profile

        • 14.8.2 Bayer Migraine Drugs Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Kowa Pharmaceuticals America

        • 14.9.1 Kowa Pharmaceuticals America Company Profile

        • 14.9.2 Kowa Pharmaceuticals America Migraine Drugs Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Endo International

        • 14.10.1 Endo International Company Profile

        • 14.10.2 Endo International Migraine Drugs Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Johnson & Johnson

        • 14.11.1 Johnson & Johnson Company Profile

        • 14.11.2 Johnson & Johnson Migraine Drugs Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Eli Lilly

        • 14.12.1 Eli Lilly Company Profile

        • 14.12.2 Eli Lilly Migraine Drugs Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 GlaxoSmithKline

        • 14.13.1 GlaxoSmithKline Company Profile

        • 14.13.2 GlaxoSmithKline Migraine Drugs Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Migraine Drugs Industry Research Conclusions

    • 15.2 Migraine Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Migraine Drugs Industry Market Size (2018-2029)

    • Figure China Migraine Drugs Production Volume, Production Value and Growth Rate of Sumatriptan (2018-2029)

    • Figure China Migraine Drugs Production Volume, Production Value and Growth Rate of Rizatriptan (2018-2029)

    • Figure China Migraine Drugs Production Volume, Production Value and Growth Rate of Other Drug (2018-2029)

    • Figure China Migraine Drugs Production Volume, Production Value and Growth Rate of Zolmitriptan (2018-2029)

    • Figure China Migraine Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Migraine Drugs Sales Volume, Sales Value and Growth Rate of Household Use (2018-2029)

    • Figure China Migraine Drugs Sales Volume, Sales Value and Growth Rate of Clinics (2018-2029)

    • Figure China Migraine Drugs Sales Volume, Sales Value and Growth Rate of Hospitals (2018-2029)

    • Figure North China Migraine Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Migraine Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Migraine Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Migraine Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Migraine Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Migraine Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Migraine Drugs Market Size and Growth Rate from 2018-2029

    • Figure Migraine Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Migraine Drugs Market Share by Type in 2018

    • Figure China Migraine Drugs Market Share by Type in 2023

    • Figure China Migraine Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Migraine Drugs Production Volume and Growth Rate of Sumatriptan (2018-2023)

    • Figure China Migraine Drugs Production Volume and Growth Rate of Rizatriptan (2018-2023)

    • Figure China Migraine Drugs Production Volume and Growth Rate of Other Drug (2018-2023)

    • Figure China Migraine Drugs Production Volume and Growth Rate of Zolmitriptan (2018-2023)

    • Figure China Migraine Drugs Market Share by Application in 2018

    • Figure China Migraine Drugs Market Share by Application in 2023

    • Figure China Migraine Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Migraine Drugs Market Size and Growth Rate of Others (2018-2023)

    • Figure China Migraine Drugs Market Size and Growth Rate of Household Use (2018-2023)

    • Figure China Migraine Drugs Market Size and Growth Rate of Clinics (2018-2023)

    • Figure China Migraine Drugs Market Size and Growth Rate of Hospitals (2018-2023)

    • Table China Migraine Drugs Production Volume by Region (2018-2023)

    • Table China Migraine Drugs Production Volume Share by Region (2018-2023)

    • Figure China Migraine Drugs Production Volume Share by Region (2018-2023)

    • Table China Migraine Drugs Production Value by Region (2018-2023)

    • Table China Migraine Drugs Production Value Share by Region (2018-2023)

    • Figure China Migraine Drugs Production Value Share by Region (2018-2023)

    • Table China Migraine Drugs Sales Volume by Region (2018-2023)

    • Table China Migraine Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Migraine Drugs Sales Volume Share by Region (2018-2023)

    • Table China Migraine Drugs Sales Value by Region (2018-2023)

    • Table China Migraine Drugs Sales Value Share by Region (2018-2023)

    • Figure China Migraine Drugs Sales Value Share by Region (2018-2023)

    • Table North China Migraine Drugs Production Volume by Type (2018-2023)

    • Table North China Migraine Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Migraine Drugs Production Volume Share by Type (2018-2023)

    • Table North China Migraine Drugs Sales Volume by Application (2018-2023)

    • Table North China Migraine Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Migraine Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Migraine Drugs Production Volume by Type (2018-2023)

    • Table Central China Migraine Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Migraine Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Migraine Drugs Sales Volume by Application (2018-2023)

    • Table Central China Migraine Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Migraine Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Migraine Drugs Production Volume by Type (2018-2023)

    • Table South China Migraine Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Migraine Drugs Production Volume Share by Type (2018-2023)

    • Table South China Migraine Drugs Sales Volume by Application (2018-2023)

    • Table South China Migraine Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Migraine Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Migraine Drugs Production Volume by Type (2018-2023)

    • Table East China Migraine Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Migraine Drugs Production Volume Share by Type (2018-2023)

    • Table East China Migraine Drugs Sales Volume by Application (2018-2023)

    • Table East China Migraine Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Migraine Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Migraine Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Migraine Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Migraine Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Migraine Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Migraine Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Migraine Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Migraine Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Migraine Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Migraine Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Migraine Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Migraine Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Migraine Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Migraine Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Migraine Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Migraine Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Migraine Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Migraine Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Migraine Drugs Sales Volume Share by Application (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Migraine Drugs Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Migraine Drugs Revenue, Price and Gross (2018-2023)

    • Table Allergan Company Profile

    • Table Allergan Migraine Drugs Revenue, Price and Gross (2018-2023)

    • Table Winston Pharmaceuticals Company Profile

    • Table Winston Pharmaceuticals Migraine Drugs Revenue, Price and Gross (2018-2023)

    • Table Teva Company Profile

    • Table Teva Migraine Drugs Revenue, Price and Gross (2018-2023)

    • Table Ethypharm Company Profile

    • Table Ethypharm Migraine Drugs Revenue, Price and Gross (2018-2023)

    • Table Impax Company Profile

    • Table Impax Migraine Drugs Revenue, Price and Gross (2018-2023)

    • Table Bayer Company Profile

    • Table Bayer Migraine Drugs Revenue, Price and Gross (2018-2023)

    • Table Kowa Pharmaceuticals America Company Profile

    • Table Kowa Pharmaceuticals America Migraine Drugs Revenue, Price and Gross (2018-2023)

    • Table Endo International Company Profile

    • Table Endo International Migraine Drugs Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Migraine Drugs Revenue, Price and Gross (2018-2023)

    • Table Eli Lilly Company Profile

    • Table Eli Lilly Migraine Drugs Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Migraine Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US